Recent Publications in Eating and Endocrine Disorders

Elfers C, Ralston M, Roth CL. Studies of Different Female Rat Models of Hypothalamic Obesity. J Pediatr Endocrinol Metab 2011;24(3-4):131–7.

Elfers C, Roth CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Front Endocrin 2011; 2:78.

Elfers CT, Simmons JH, Roth CL. Glucagon-Like-Peptide-1 agonist  exendin-4 leads to reduction of weight and caloric intake in a rat model of hypothalamic obesity. Horm Res Paediatr 2012; 78:47-53.

Flores CG, Valcante G, Guter S, Zaytoun A, Wray E, Bell L, Jacob S, Lewis MH, Driscoll DJ, Cook EH Jr, Kim SJ.  Repetitive behavior profiles: Consistency across autism spectrum disorder cohorts and divergence from Prader-Willi syndrome.  J Neurodev Disord. 2011 Dec;3(4):316-24. Epub 2011 Sep 1.

Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 2003; 88: 5227-31.

Henkhaus RS, Kim SJ, Kimonis VE, Gold JA, Dykens EM, Driscoll DJ, Butler MG.  Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome.  Genet Test Mol Biomarkers. 2012 Mar;16(3):178-86. Epub 2011 Oct 6.

Kim SJ, Miller JL, Kuipers PJ, German JR, Beaudet AL, Sahoo T, Driscoll DJ.   Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes.  Eur J Hum Genet. 2012 Mar;20(3):283-90. doi: 10.1038/ejhg.2011.187. Epub 2011 Nov 2.

Krone N, Reisch N, Idkowiak J, Dhir V, Ivison HE, Hughes BA, Rose IT, O’Neil DM, Vijzelaar R, Smith MJ, MacDonald F, Cole TR, Adolphs N, Barton JS, Blair EM, Braddock SR, Collins F, Cragun DL, Dattani MT, Day R, Dougan S, Feist M, Gottschalk ME, Gregory JW, Haim M, Harrison R, Olney AH, Hauffa BP, Hindmarsh PC, Hopkin RJ, Jira PE, Kempers M, Kerstens MN, Khalifa MM, Köhler B, Maiter D, Nielsen S, O’Riordan SM, Roth CL, Shane KP, Silink M, Stikkelbroeck NM, Sweeney E, Szarras-Czapnik M, Waterson JR, Williamson L, Hartmann MF, Taylor NF, Wudy SA, Malunowicz EM, Shackleton CH, Arlt W. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab. 2012 Feb;97(2):E257-67. PMID: 22162478

Linsel-Nitschke P, Heeren J, Aherrahrou Z, Bruse P, Gieger C, Illig T, Prokisch H, Heim K, Doering A, Peters A, Meitinger T, Wichmann HE, Hinney A, Reinehr T, Roth CL, Ortlepp JR, Soufi M, Sattler AM, Schaefer J, Stark K, Hengstenberg C, Schaefer A, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis. 2010 Jan;208(1):183-9. PMID: 19660754

Reinehr T, Woelfle J, Wunsch R, Roth CL. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab 2012; 97(6): 2143-50.

Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998; 138:89-91

Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, Muller HL. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr Res 2007; 61:496-501.

Roth CL, Blevins JE, Ralston M, Elfers C, Ogimoto K, Kaiyala K, Morton GJ. A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients. Pediatr Res 2011; 69(3):230-6.

Roth CL, Gebhardt U, Muller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring) 2011; 19:36–42.

Roth CL, Aylward E, Liang O, Kleinhans N, Pauley G, Schur E. Functional neuroimaging in craniopharyngioma: a useful tool to better understand hypothalamic obesity? Obesity Facts 2012; 5(2): 243-53.

Roth CL, Elfers, C, Kratz, M, Hoofnagle AN. Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. Journal of Obesity  2011; 2011: 495101.

Roth CL. Hypothalamic obesity in patients with craniopharyngioma: Profound changes of several weight regulatory circuits. Front Endocrin 2011; 2:49.

Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE, Kowdley KV.  Vitamin D deficiency in obese rats exacerbates non-alcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation.  Hepatology 2012; 55(4): 1103-11.

Roth CL, Elfers C, Gebhardt U, Muller HL, Reinehr T. Brain-Derived Neurotrophic Factor and its Relation to Leptin in Obese Children before and after Weight Loss. Metabolism 2013 Feb;62(2):226-34. doi: 10.1016/j.metabol.2012.08.001.12.

Chow EJ, Pihoker C, Friedman DL, Lee SJ, McCune JS, Wharton C, Roth CL, Baker KS. Glucocorticoids and insulin resistance in children with acute lymphoblasticleukemia. Pediatr Blood Cancer. 2013 Apr;60(4):621-6. doi: 10.1002/pbc.24364. Epub 2012 Oct 5. PubMed

Comments are closed.